Continuing GLP-1/GIP agonist therapy prior to elective upper endoscopy increases the risk for residual gastric volume, but ...

MRI-based prostate cancer screening of the general population does not increase detection of clinically significant prostate cancer, but it does improve the benefit-vs-harm profile of PSA testing ...

Please provide your email address to receive an email when new articles are posted on . DENVER — Treatment with a novel therapeutic led to clinically significant improvement in cognition for young ...

Full results published in the New England Journal of Medicine and presented at ATS 2025 International Conference BATURA builds upon the previous Phase III MANDALA and DENALI trials and in totality, ...

Residual gastric volume precluded endoscopic examination ...

The MyProstateScore 2.0 urine test captures 17 biomarkers of clinically significant prostate cancer, independent of PSA. A positive result can rule in and a negative result can rule out the need for ...

Among 5,735 examinations in 5,215 patients, 1,514 examinations showed clinically significant prostate cancer. On both the internal test set of 400 exams and an external test set of 204 exams, the deep ...

But does it cost too much?

Daiichi Sankyo and AstraZeneca’s DATROWAY is the first and only therapy to significantly improve overall survival versus chemotherapy in this patient population DATROWAY also demonstrated a highly ...

LEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat ...

Please provide your email address to receive an email when new articles are posted on . Demonstrated in this video is the identification of a clinically significant labral injury lesion in a disabled ...